Bio-Techne on Wednesday announced the European launch and CE-IVD marking of its RNAscope ISH Probe High Risk HPV assay to detect high-risk human papillomavirus (HPV) in oropharyngeal squamous cell carcinoma patients.
RNAscope in situ hybridization (ISH) is a highly sensitive and specific spatial biology technology, Bio-Techne said.
The assay enables users to visualize and localize biomarker expression patterns by light microscopy. It is used in clinical laboratories with the CE-IVD marked Bond RNAscope Brown detection kit on the automated Leica Biosystems Bond-III stainer.
The assay detects high-risk HPV types 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82.